N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is a complex organic compound with CAS number 64-86-8 and molecular formula C22H25NO6. This substance has a molecular weight of 399.4 g/mol and belongs to the benzoheptalene derivative family. It is classified as a highly hazardous chemical with mutagenic properties (Muta. 1B) and acute toxicity (Acute Tox. 2), requiring strict handling protocols and safety measures.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is an organic solid with a molecular weight of 399.4 g/mol. The compound contains multiple methoxy groups and an acetamide functionality, suggesting moderate polarity. Its complex benzoheptalene structure with four methoxy substituents likely influences its solubility characteristics. The presence of both polar (methoxy, acetamide) and aromatic regions indicates potential solubility in polar organic solvents.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is primarily used in pharmaceutical research and specialized chemical synthesis applications. Due to its complex structure and high toxicity classification, its use is typically restricted to controlled laboratory environments and specific industrial processes requiring expert handling. The compound may serve as an intermediate in organic synthesis or as a research chemical for specialized pharmaceutical development projects.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide requires maximum safety precautions due to its Acute Tox. 2 and Muta. 1B classifications. Essential protective equipment includes chemical-resistant gloves, full face protection, and respiratory protection. Work must be conducted in a well-ventilated area or fume hood. Avoid skin contact, inhalation, and ingestion completely. Use only in controlled laboratory environments with proper emergency procedures in place.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide must be stored in a secure, controlled environment away from heat, light, and moisture. Keep containers tightly closed in a cool, dry, well-ventilated area with restricted access due to its high toxicity. Store separately from incompatible materials and ensure proper labeling with GHS08 and GHS06 pictograms. Regular inventory checks and proper containment measures are essential for this dangerous substance.

Immediate medical attention is required for any contact with N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide due to its Acute Tox. 2 classification. For skin contact, remove contaminated clothing and flush with water for at least 15 minutes. If inhaled, move to fresh air immediately. In case of eye contact, rinse thoroughly with water. Never induce vomiting if ingested. Contact poison control center and seek emergency medical care immediately while providing the safety data sheet.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide requires disposal as hazardous waste through licensed waste management companies only. Due to its mutagenic properties (Muta. 1B) and acute toxicity, standard disposal methods are prohibited. Collection, transport, and disposal must comply with local and EU hazardous waste regulations. Never dispose of in regular waste streams, sewers, or environment. Maintain detailed disposal records and use only authorized hazardous waste disposal facilities.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is classified as ADR Class 6.1 (toxic substances), Packing Group I, indicating maximum danger level for transport. Specialized hazardous goods packaging, labeling, and documentation are mandatory. Only qualified dangerous goods transporters may handle shipments. Proper UN identification, emergency response information, and compliance with international dangerous goods regulations are required. Temperature-controlled transport may be necessary depending on specific storage requirements.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is subject to strict EU regulations under REACH and CLP due to its Muta. 1B and Acute Tox. 2 classifications. While not currently listed as SVHC, its mutagenic properties may trigger additional restrictions. Users must comply with occupational safety regulations, proper classification and labeling requirements, and may need authorization for certain uses. Regular safety assessments and risk management measures are mandatory.

N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide is available through OYSI, a specialized European distributor of technical chemicals. Due to its high toxicity classification (Acute Tox. 2, Muta. 1B), purchase requires proper documentation, safety protocols, and compliance verification. OYSI provides comprehensive safety documentation, proper packaging, and regulatory support for this controlled substance. Contact OYSI directly for availability, technical specifications, and regulatory compliance assistance for European markets.